$FOLD
AMICUS THERAPEUTICS, INC. Stock $fold

$fold Overview Financials Valuation SEC Filings Company Website

2012 Q4 Form 10-Q Financial Statement

#000110465912074314 Filed on November 06, 2012

Income Statement

Concept	2012 Q4	2012 Q3	2011 Q3
Revenue	$0.00	$0.00	$5.798M
YoY Change	-100.0%	-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.460M	$5.000M	$4.840M
YoY Change	13.78%	3.31%	24.42%
% of Gross Profit
Research & Development	$11.05M	$11.50M	$13.71M
YoY Change	-23.26%	-16.13%	54.75%
% of Gross Profit
Depreciation & Amortization	$430.0K	$420.0K	$380.0K
YoY Change	22.86%	10.53%	-25.49%
% of Gross Profit
Operating Expenses	$15.92M	$16.92M	$18.93M
YoY Change	-14.68%	-10.65%	42.67%
Operating Profit		-$16.92M	-$13.13M
YoY Change		28.8%
Interest Expense	$2.660M	$19.00K	$32.00K
YoY Change	259.46%	-40.63%	-101.53%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	$0.00
YoY Change
Pretax Income	-$13.26M	-$16.29M	-$9.759M
YoY Change	7.89%	66.92%	-36.46%
Income Tax	-$3.250M	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$10.02M	-$16.29M	-$9.759M
YoY Change	15.62%	66.92%	-36.46%
Net Earnings / Revenue			-168.32%
Basic Earnings Per Share
Diluted Earnings Per Share	-$204.5K	-$335.8K	-$279.0K
COMMON SHARES
Basic Shares Outstanding	49.45M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2012 Q4	2012 Q3	2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$99.10M	$106.2M	$69.50M
YoY Change	77.92%	52.81%	20.66%
Cash & Equivalents	$33.97M	$24.27M	$22.81M
Short-Term Investments	$65.20M	$81.90M	$46.70M
Other Short-Term Assets	$2.270M	$3.077M	$3.000M
YoY Change	-61.54%	2.57%	3.45%
Inventory
Prepaid Expenses
Receivables	$3.200M
Other Receivables	$0.00
Total Short-Term Assets	$104.6M	$112.5M	$76.40M
YoY Change	56.97%	47.22%	26.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.029M	$5.293M	$1.800M
YoY Change	106.28%	194.06%	-40.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$442.0K	$442.0K	$700.0K
YoY Change	-37.66%	-36.86%	133.33%
Total Long-Term Assets	$5.471M	$5.735M	$2.500M
YoY Change	73.85%	129.4%	-24.24%
TOTAL ASSETS
Total Short-Term Assets	$104.6M	$112.5M	$76.40M
Total Long-Term Assets	$5.471M	$5.735M	$2.500M
Total Assets	$110.1M	$118.2M	$78.90M
YoY Change	57.73%	49.82%	23.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.115M	$9.400M	$8.100M
YoY Change	-17.9%	16.05%	19.12%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$400.0K	$500.0K	$1.300M
YoY Change	-60.0%	-61.54%	0.0%
Total Short-Term Liabilities	$9.243M	$9.930M	$18.60M
YoY Change	-52.0%	-46.61%	129.63%
LONG-TERM LIABILITIES
Long-Term Debt	$300.0K	$400.0K	$100.0K
YoY Change		300.0%	-92.86%
Other Long-Term Liabilities	$31.30M	$31.10M	$23.30M
YoY Change	49.76%	33.48%	513.16%
Total Long-Term Liabilities	$31.60M	$31.50M	$23.40M
YoY Change	51.2%	34.62%	350.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.243M	$9.930M	$18.60M
Total Long-Term Liabilities	$31.60M	$31.50M	$23.40M
Total Liabilities	$40.90M	$41.50M	$42.10M
YoY Change	1.74%	-1.43%	216.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$318.9M	-$308.9M
YoY Change	18.06%
Common Stock	$388.1M	$385.6M
YoY Change	29.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$69.22M	$76.76M	$36.80M
YoY Change
Total Liabilities & Shareholders Equity	$110.1M	$118.2M	$78.90M
YoY Change	57.73%	49.82%	23.67%

Cashflow Statement

Concept	2012 Q4	2012 Q3	2011 Q3
OPERATING ACTIVITIES
Net Income	-$10.02M	-$16.29M	-$9.759M
YoY Change	15.62%	66.92%	-36.46%
Depreciation, Depletion And Amortization	$430.0K	$420.0K	$380.0K
YoY Change	22.86%	10.53%	-25.49%
Cash From Operating Activities	-$7.370M	-$7.200M	-$12.99M
YoY Change	-41.13%	-44.57%	17.45%
INVESTING ACTIVITIES
Capital Expenditures	-$150.0K	-$230.0K	-$220.0K
YoY Change	-85.29%	4.55%	266.67%
Acquisitions
YoY Change
Other Investing Activities	$16.77M	-$15.01M	$10.53M
YoY Change	0.36%	-242.55%	17.39%
Cash From Investing Activities	$16.61M	-$15.23M	$10.31M
YoY Change	5.86%	-247.72%	15.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	460.0K	17.85M	-300.0K
YoY Change	-248.39%	-6050.0%	-18.92%
NET CHANGE
Cash From Operating Activities	-7.370M	-7.200M	-12.99M
Cash From Investing Activities	16.61M	-15.23M	10.31M
Cash From Financing Activities	460.0K	17.85M	-300.0K
Net Change In Cash	9.700M	-4.580M	-2.980M
YoY Change	239.16%	53.69%	18.25%
FREE CASH FLOW
Cash From Operating Activities	-$7.370M	-$7.200M	-$12.99M
Capital Expenditures	-$150.0K	-$230.0K	-$220.0K
Free Cash Flow	-$7.220M	-$6.970M	-$12.77M
YoY Change	-37.22%	-45.42%	16.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Share Based Compensation ShareBasedCompensation	7243000	USD
	fold	Change In Fair Value Of Warrant Liability Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInFairValueOfWarrantLiabilityAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	1941000	USD
	fold	Collaboration Revenue CollaborationRevenue	4980000	USD
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	AMICUS THERAPEUTICS INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001178879
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2012-09-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2012Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49449489	shares
CY2012Q3	us-gaap	Assets Assets	118211000	USD
CY2011Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	8504000	USD
CY2012Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9930000	USD
CY2012Q3	us-gaap	Stockholders Equity StockholdersEquity	76759000	USD
CY2012Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	118211000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	121875000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24273000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	18411000	USD
	us-gaap	Operating Expenses OperatingExpenses	447321000	USD
	fold	Research Revenue ResearchRevenue	57493000	USD
	fold	Collaboration Revenue CollaborationRevenue	64382000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4743000	USD
	fold	Research Revenue ResearchRevenue	11591000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-37008000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-38770000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-314337000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-329100000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	304846000	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	16916000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-16916000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-16290000	USD
CY2012Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9507000	USD
CY2012Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8080000	USD
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34654206	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34654206	shares
CY2012Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49360659	shares
CY2012Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49360659	shares
CY2011Q3	fold	Research Revenue ResearchRevenue	4138000	USD
CY2011Q3	fold	Collaboration Revenue CollaborationRevenue	1660000	USD
CY2011Q3	us-gaap	Sales Revenue Net SalesRevenueNet	5798000	USD
CY2011Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	13711000	USD
CY2011Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	380000	USD
CY2011Q3	us-gaap	Operating Expenses OperatingExpenses	18932000	USD
CY2011Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-13134000	USD
CY2011Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	31000	USD
CY2011Q3	us-gaap	Interest Expense InterestExpense	32000	USD
CY2011Q3	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-3376000	USD
CY2011Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9759000	USD
CY2011Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2011Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	34979702	shares
	us-gaap	Net Income Loss NetIncomeLoss	-35750000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	37000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	37000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-308837000	USD
CY2011Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	30034000	USD
CY2011Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	5043000	USD
CY2011Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5903000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	66648000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2438000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	709000	USD
CY2011Q4	us-gaap	Assets Assets	69795000	USD
CY2011Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9708000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	299285000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-270104000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	29592000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25668000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.03
CY2011Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4841000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-35750000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.88
	us-gaap	Sales Revenue Net SalesRevenueNet	15804000	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16290000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-11000	USD
CY2011Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9759000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69795000	USD
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	-9759000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29572000	USD
CY2012Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	81905000	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-1859000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2826000	USD
	fold	Conversion Of Notes Payable To Preferred Stock ConversionOfNotesPayableToPreferredStock	5000000	USD
CY2011Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	1044000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19256000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	407000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q3	us-gaap	Assets Current AssetsCurrent	112476000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-325446000	USD
	fold	Change In Fair Value Of Warrant Liability Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInFairValueOfWarrantLiabilityAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	-2022000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-28000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1139000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	33000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38737000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	33000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1243000	USD
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.34
	fold	Research Revenue ResearchRevenue	10824000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	36455000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15963000	USD
	us-gaap	Operating Expenses OperatingExpenses	53661000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-37857000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	136000	USD
	us-gaap	Interest Expense InterestExpense	121000	USD
	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-2022000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	70000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-35750000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	34544768	shares
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	447000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-267000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-192000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-280000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	78255000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38770000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	47097000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	398000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	30760000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-56042000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-100079000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	128158000	USD
	us-gaap	Restructuring Charges RestructuringCharges	1522000	USD
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	1030000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	40000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	940000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	359000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	995000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	81017000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-621000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-6762000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-1395000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	24273000	USD
CY2012Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	11499000	USD
	us-gaap	Interest Paid InterestPaid	121000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-11000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-38770000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11347000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	418000	USD
CY2011Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11000	USD
CY2011Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9770000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	20000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	47445000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	20000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16270000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	3000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	3000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-35747000	USD
	fold	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	148951000	USD
	fold	Accretion Of Redeemable Convertible Preferred Stock AccretionOfRedeemableConvertiblePreferredStock	802000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	99320000	USD
	fold	Beneficial Conversion Feature Related To Issuance Of Series C Redeemable Convertible Preferred Stock BeneficialConversionFeatureRelatedToIssuanceOfSeriesCRedeemableConvertiblePreferredStock	19424000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-36901000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-26370000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-220976000	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22810000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4000	USD
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	33000	USD
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	13200000	USD
CY2012Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	15300000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62000000	USD
CY2010Q1	fold	Portion Of Share Purchased In One Unit PortionOfSharePurchasedInOneUnit	0.375	shares
	fold	Warrant Term WarrantTerm	P4Y
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0	USD
CY2012Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	4.43
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4167000	USD
CY2010Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4950000	shares
CY2011Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	30034000	USD
CY2012Q3	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	81942000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3300000	USD
	fold	Fair Value Inputs Number Of Inputs Used In Fair Value Classification FairValueInputsNumberOfInputsUsedInFairValueClassification	6	item
	fold	Exercise Period Of Warrant On Or After Issued ExercisePeriodOfWarrantOnOrAfterIssued	P6M
CY2012Q1	us-gaap	Share Price SharePrice	5.70
CY2010Q1	fold	Number Of Shares Of Common Stock Sold In One Unit NumberOfSharesOfCommonStockSoldInOneUnit	1	shares
CY2010Q1	fold	Number Of Warrants Sold In One Unit NumberOfWarrantsSoldInOneUnit	1	shares
CY2010Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1850000	shares
CY2010Q1	us-gaap	Share Price SharePrice	3.74
CY2011Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	25668000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	24273000	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	12000	USD
CY2012Q3	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	44000	USD
CY2011Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	8000	USD
CY2012Q3	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	7000	USD
CY2011Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	55698000	USD
CY2012Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	106178000	USD
CY2011Q4	fold	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	55702000	USD
CY2012Q3	fold	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	106215000	USD
CY2012Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	11500000	shares
CY2010Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17100000	USD
CY2012Q1	fold	Proceeds From Issuance Of Common Stock Gross ProceedsFromIssuanceOfCommonStockGross	65600000	USD
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2011Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1948000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	463000	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	4630000	USD
CY2011	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0.00	pure
CY2011	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P2Y2M1D
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P1Y5M1D
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9428000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	719535000	USD
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.760	pure
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	801558000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18056000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	193441000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5000000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	5587000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	3853000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	80195000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	14308000	USD
	us-gaap	Interest Expense InterestExpense	2410000	USD
	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	1041000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	252000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5463000	USD
	fold	Deemed Dividend DeemedDividend	19424000	USD
	fold	Preferred Stock Accretion PreferredStockAccretion	802000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	37000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	525000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-308874000	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	522000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	40480000	USD
	fold	Share Based Compensation Non Employees ShareBasedCompensationNonEmployees	853000	USD
	fold	Stock Based License Payments StockBasedLicensePayments	1220000	USD
	fold	Change In Fair Value Of Warrant Liability Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInFairValueOfWarrantLiabilityAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	1041000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-388000	USD
	fold	Beneficial Conversion Feature Related To Bridge Financing BeneficialConversionFeatureRelatedToBridgeFinancing	135000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	143022000	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	3184000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3077000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2677000	USD
	fold	Proceeds From Exercise Of Warrants Common And Preferred ProceedsFromExerciseOfWarrantsCommonAndPreferred	264000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	966000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	345328000	USD
	us-gaap	Interest Paid InterestPaid	72000	USD
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	5611000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	4753000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	44255885	shares
	us-gaap	Interest Paid InterestPaid	2104000	USD
CY2012Q3	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-553000	USD
	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	1941000	USD
CY2011Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	30030000	USD
CY2011	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.673	pure
CY2011	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0028	pure
CY2012Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	398000	USD
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0019	pure
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0.00	pure
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	1900000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	2000000	USD
CY2010Q1	fold	Proceeds From Issuance Of Common Stock Gross ProceedsFromIssuanceOfCommonStockGross	18500000	USD
CY2012Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	600000	USD
CY2011Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	3400000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-16290000	USD
CY2012Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3889000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	235000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	20000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	33000	USD
CY2012Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-308874000	USD
CY2012Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48513647	shares
CY2012Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	81942000	USD
CY2012Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5293000	USD
CY2012Q3	us-gaap	Other Assets Current OtherAssetsCurrent	3077000	USD
CY2012Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	92000	USD
CY2012Q3	us-gaap	Interest Expense InterestExpense	19000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21000	USD
CY2012Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	3184000	USD
CY2012Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	442000	USD
	fold	Collaboration Revenue CollaborationRevenue	6820000	USD
CY2012Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9428000	USD
CY2012Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	502000	USD
CY2012Q3	us-gaap	Common Stock Value CommonStockValue	554000	USD
CY2012Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	385042000	USD
CY2012Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	37000	USD
	us-gaap	Interest Expense InterestExpense	77000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	39226000	USD
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4995000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14909000	USD
CY2012Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	422000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1284000	USD
	us-gaap	Operating Expenses OperatingExpenses	55419000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	27235000	USD

Files In Submission

Name	View Source	Status
0001104659-12-074314-index-headers.html	Edgar Link	pending
0001104659-12-074314-index.html	Edgar Link	pending
0001104659-12-074314.txt	Edgar Link	pending
0001104659-12-074314-xbrl.zip	Edgar Link	pending
a12-20117_110q.htm	Edgar Link	pending
a12-20117_1ex10d1.htm	Edgar Link	pending
a12-20117_1ex10d2.htm	Edgar Link	pending
a12-20117_1ex31d1.htm	Edgar Link	pending
a12-20117_1ex31d2.htm	Edgar Link	pending
a12-20117_1ex32d1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
fold-20120930.xml	Edgar Link	completed
fold-20120930.xsd	Edgar Link	pending
fold-20120930_cal.xml	Edgar Link	unprocessable
fold-20120930_def.xml	Edgar Link	unprocessable
fold-20120930_lab.xml	Edgar Link	unprocessable
fold-20120930_pre.xml	Edgar Link	unprocessable
g201171ke17i001.jpg	Edgar Link	pending
g201171ke17i002.jpg	Edgar Link	pending
g201171ke17i003.jpg	Edgar Link	pending
g201171ke19i001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOLD
AMICUS THERAPEUTICS, INC. Stock $fold

2012 Q4 Form 10-Q Financial Statement

#000110465912074314 Filed on November 06, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOLD AMICUS THERAPEUTICS, INC. Stock $fold

2012 Q4 Form 10-Q Financial Statement

#000110465912074314 Filed on November 06, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOLD
AMICUS THERAPEUTICS, INC. Stock $fold